ARCHIVES

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

PSA Level Predicts Survival For Prostate Cancer

October 25, 2002

Medicare plans to cut oncology payments on Jan. 1 unless Congress intervenes.

October 17, 2003

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013

In Brief: Congressmen Press Or More Exploratory Grant Money: Murphy Reelected By UICC

August 6, 1976

Lame Duck NCI Director: Cancer Centers Should Run Cancer Clinical Trials System

June 25, 2010